341
Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer
Condition(s):Breast Cancer; Brain MetastasesLast Updated:March 2, 2022Withdrawn
Vinorelbine: 523 Clinical Trials, Page 35 of 53
Hide Studies Not Open or Pending
342
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Condition(s):Cervical CancerLast Updated:March 23, 2023Recruiting
343
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
Condition(s):Lung CancerLast Updated:March 27, 2017Terminated
344
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Condition(s):Alveolar Rhabdomyosarcoma; Botryoid-Type Embryonal Rhabdomyosarcoma; Embryonal Rhabdomyosarcoma; Rhabdomyosarcoma; Sclerosing Rhabdomyosarcoma; Spindle Cell RhabdomyosarcomaLast Updated:March 27, 2023Suspended
345
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma
Condition(s):Non-Hodgkin’s Lymphoma (CD20+)Last Updated:January 15, 2016Completed
346
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
Condition(s):Non-small Cell Lung CancerLast Updated:September 19, 2012Completed
347
Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
Condition(s):Breast CancerLast Updated:June 15, 2022Completed
348
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
Condition(s):Metastatic Breast CancerLast Updated:March 3, 2023Active, not recruiting
349
The ‘MADe IT’ Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:March 23, 2017Completed
350
Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy
Condition(s):Non-small Cell Lung CarcinomaLast Updated:November 28, 2017Completed